36 Results for "

CXCR7

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "CXCR7" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
  • Recombinant Proteins Recommended:
111
111 Publications Verification
Cat. No.: HY-10046
CAS No.: 110078-46-1
Purity:  99.90%
Synonyms: AMD 3100; JM3100; SID791
Target:  

CXCR HIV

Plerixafor (AMD 3100) is a selective CXCR4 antagonist with an IC50 of 44 nM. Plerixafor, an immunostimulant and a hematopoietic stem cell (HSC) mobilizer, is an allosteric agonist of CXCR7. Plerixafor inhibits HIV-1 and HIV-2 replication with an EC50 of 1-10 nM [7].
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P1102
CAS No.: 368874-34-4
Target:  

CXCR HIV

Research Areas:  

Infection Cancer

TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-110318
CAS No.: 1785665-61-3
Purity:  98.28%
Target:  

CXCR

Research Areas:  

Inflammation/Immunology Cancer

VUF11207 fumarate is a CXCR7 agonist that binds specifically to CXCR7. VUF11207 fumarate reduces CXCL12-mediated osteoclastogenesis and bone resorption by inhibiting ERK phosphorylation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100677
CAS No.: 1378524-41-4
Purity:  94.56%
Target:  

CXCR

Research Areas:  

Endocrinology

VUF11207 (Compound 29) is a CXCR7 agonist and a high-potency CXCR7 (pKi of 8.1) ligand that induces recruitment of β-arrestin2 (pEC50 of 8.8) and subsequent internalization (pEC50 of 7.9) of CXCR7 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139643
CAS No.: 1613021-99-0
Purity:  99.85%
Research Areas:  

Inflammation/Immunology Cancer

CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-142617
CAS No.: 2178049-58-4
Purity:  98.81%
Target:  

CXCR

ACT-1004-1239 is a potent, selective, orally active CXCR7 antagonist with an IC50 value of 3.2 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139643A
CAS No.: 2990472-61-0
Purity:  99.41%
Research Areas:  

Inflammation/Immunology Cancer

CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 hydrochloride is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1682A
Synonyms: POL6326 TFA
Target:  

CXCR Arrestin

Research Areas:  

Cancer

Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide TFA shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide TFA is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-D0976
CAS No.: 202983-32-2
Research Areas:  

Infection

NF279 is a selective P2X1 receptor antagonist and NTPDase inhibitor, with a P2X1 IC50 value of 19 nM. NF279 suppresses GABA-evoked currents, reduces ATP-excited respiratory activity, alters hypoglossal nerve burst parameters, and blocks CXCR4, CCR5, CXCR3, and CXCR7-mediated calcium responses. NF279 arrests HIV-1 fusion downstream of CD4 binding, inhibits R5- and X4-tropic HIV-1 strains. NF279 can be used for the research of HIV-1 infection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1682
CAS No.: 1051366-32-5
Synonyms: POL6326
Target:  

CXCR Arrestin

Research Areas:  

Cancer

Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects .
loading...
    loading...
Cat. No.: HY-112154
CAS No.: 2227426-37-9
Purity:  98.71%
Target:  

CXCR

CXCR7 modulator 2 is a modulator of C-X-C Chemokine Receptor Type 7 (CXCR7), with a Ki of 13 nM.
loading...
    loading...
Cat. No.: HY-107987
CAS No.: 2231812-31-8
Purity:  99.50%
Target:  

CXCR

Research Areas:  

Endocrinology

CXCR7 modulator 1 (compound 25) is a potent and orally bioavailable peptoid hybrid CXCR7 modulator, with a Ki of 9 nM .
loading...
    loading...
Cat. No.: HY-167851
CAS No.: 1226686-54-9
Target:  

CXCR

Research Areas:  

Neurological Disease Cancer

CCX662 is a selective CXCR7 inhibitor with human IC50 values of 9 nM (buffer) and 18 nM (100% human serum), and rat IC50 of 14 nM (100% rat serum). CCX662 blocks CXCL12 binding to CXCR7, inhibits CXCR4-directed trans-endothelial migration of CXCR4 +/CXCR7 + cells. CCX662 can be used for the research of glioblastoma multiforme .
loading...
    loading...
Cat. No.: HY-123813
CAS No.: 1226686-36-7
Purity:  98.73%
Target:  

CXCR Arrestin

Research Areas:  

Cancer

CCX-777 is an orthosteric binder and partial agonist of CXCR7/ACKR3. CCX-777 induces the recruitment of β-arrestin 2 and affects the rebinding of chemokines to ACKR3. CCX-777 functions to stabilize the ACKR3 receptor and promotes the formation of a monodisperse, stable complex of the receptor in DDM/CHS micelles. CCX-777 is widely used in cancer-related research .
loading...
    loading...
Cat. No.: HY-P10333A
Target:  

CXCR

LIH383 TFA is an agonist of ACKR3 (CXCR7) (EC50=0.61 nM). LIH383 TFA efficiently induces the recruitment of β-arrestin to ACKR3 but does not trigger typical G protein signaling .
loading...
    loading...
Cat. No.: HY-10046S
CAS No.: 1246819-87-3
Plerixafor-d4 is the deuterium labeled Plerixafor. Plerixafor (AMD 3100) is a selective CXCR4 antagonist with an IC50 of 44 nM. Plerixafor, an immunostimulant and a hematopoietic stem cell (HSC) mobilizer, is an allosteric agonist of CXCR7. Plerixafor inhibits HIV-1 and HIV-2 replication with an EC50 of 1-10 nM [7].
loading...
    loading...
Cat. No.: HY-107987R
CAS No.: 2231812-31-8
Research Areas:  

Endocrinology

CXCR7 modulator 1 (Standard) is the analytical standard of CXCR7 modulator 1 (HY-107987). This product is intended for research and analytical applications. CXCR7 modulator 1 (compound 25) is a potent and orally bioavailable peptoid hybrid CXCR7 modulator, with a Ki of 9 nM .
loading...
    loading...
Cat. No.: HY-W019787
CAS No.: 75513-71-2
Target:  

Opioid Receptor CXCR

Research Areas:  

Neurological Disease

BAM-12P, an endogenous opioid peptide, is a novel pro-Met-enkephalin. BAM-12P can activate human κ-opioid receptor (hKOR) with an EC50 of 101 nM and a pEC50 of 6.99. BAM-12P is a ligand for CXCR7 with an EC50 of 175 nM .
loading...
    loading...
Cat. No.: HY-P1102A
Target:  

CXCR HIV

Research Areas:  

Infection Cancer

TC14012 TFA, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 TFA is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 TFA has anti-HIV activity and anti-cancer activity .
loading...
    loading...
Cat. No.: HY-RS00162
Research Areas:  

Others

ACKR3 Human Pre-designed siRNA Set A contains three designed siRNAs for ACKR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...